Articles related to CLINICAL RESEARCH

This article poses questions surrounding the ethical challenges in brain research, highlighting the need for post-trial care responsibilities and privacy protections as neurotechnologies advance.

Pirtobrutinib offers a new line of therapy for CLL and SLL patients who have progressed after covalent BTK inhibitors and venetoclax, with a significant overall response rate and manageable adverse events.

GLP-1 receptor agonists, beyond their role in diabetes and obesity management, are showing promise in reducing alcohol cravings, potentially offering a novel approach to treating alcohol use disorder.

A recent study highlights the role of methylglyoxal (MGO) in temporarily deactivating the BRCA2 protein, crucial for DNA repair and tumor suppression.

AI is enhancing surgical care through advanced preoperative planning, intraoperative decision-making, and postoperative monitoring, promising improved patient outcomes and operational efficiency.

Recent studies indicate that while ketamine and ECT are equally effective for treating MDD, ketamine did not prove non-inferior to ECT for MDEs. Both treatments have distinct side effect profiles that are critical for clinical decision-making.